Earnings Feed
Start Free
Home/Filings/4/0001209191-15-047688
4//SEC Filing

PHARMACYCLICS INC 4

Accession 0001209191-15-047688

CIK 0000949699operating
View on SEC.govCompany Profile

Filed

May 27, 8:00 PM ET

Accepted

May 28, 6:49 PM ET

Size

66.5 KB

Accession

0001209191-15-047688

Insider Transaction Report

Form 4
Period: 2015-05-26
PHARMACYCLICS INCPCYC
Smith David Duane
Director
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−3,680→ 0 total
    Exercise: $6.52Exp: 2021-01-03→ Common Stock (3,680 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−7,500→ 0 total
    Exercise: $49.00Exp: 2022-11-09→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−413→ 0 total
    Exercise: $61.44Exp: 2023-01-02→ Common Stock (413 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−298→ 0 total
    Exercise: $79.67Exp: 2023-04-01→ Common Stock (298 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−233→ 0 total
    Exercise: $107.42Exp: 2024-04-01→ Common Stock (233 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−416→ 0 total
    Exercise: $89.58Exp: 2024-07-01→ Common Stock (416 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−7,258→ 0 total
    Exercise: $3.10Exp: 2020-01-04→ Common Stock (7,258 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−2,954→ 0 total
    Exercise: $8.12Exp: 2020-10-01→ Common Stock (2,954 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−2,409→ 0 total
    Exercise: $10.58Exp: 2021-07-01→ Common Stock (2,409 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−427→ 0 total
    Exercise: $59.28Exp: 2022-07-02→ Common Stock (427 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−313→ 0 total
    Exercise: $85.39Exp: 2023-07-01→ Common Stock (313 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−200→ 0 total
    Exercise: $139.89Exp: 2023-10-01→ Common Stock (200 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−7,500→ 0 total
    Exercise: $2.90Exp: 2019-12-17→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−3,333→ 0 total
    Exercise: $6.75Exp: 2020-07-01→ Common Stock (3,333 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−7,500→ 0 total
    Exercise: $14.26Exp: 2021-12-15→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−431→ 0 total
    Exercise: $65.56Exp: 2022-10-01→ Common Stock (431 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−7,500→ 0 total
    Exercise: $5.76Exp: 2020-12-09→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−2,480→ 0 total
    Exercise: $15.02Exp: 2022-01-03→ Common Stock (2,480 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−3,393→ 0 total
    Exercise: $6.63Exp: 2020-04-01→ Common Stock (3,393 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−1,100→ 0 total
    Exercise: $7.14Exp: 2020-08-06→ Common Stock (1,100 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−4,242→ 0 total
    Exercise: $6.01Exp: 2021-04-01→ Common Stock (4,242 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−2,917→ 0 total
    Exercise: $11.31Exp: 2021-10-03→ Common Stock (2,917 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−1,183→ 0 total
    Exercise: $28.47Exp: 2022-04-02→ Common Stock (1,183 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−3,750→ 0 total
    Exercise: $95.08Exp: 2024-05-09→ Common Stock (3,750 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−308→ 0 total
    Exercise: $115.80Exp: 2024-10-01→ Common Stock (308 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−166→ 0 total
    Exercise: $257.01Exp: 2025-04-07→ Common Stock (166 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−3,750→ 0 total
    Exercise: $74.48Exp: 2023-05-09→ Common Stock (3,750 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−217→ 0 total
    Exercise: $108.44Exp: 2024-01-02→ Common Stock (217 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−288→ 0 total
    Exercise: $124.46Exp: 2025-01-02→ Common Stock (288 underlying)
Footnotes (1)
  • [F1]Pursuant to terms of the Agreement and Plan of Reorganization (the "Merger Agreement") dated March 4, 2015, by and between the Issuer, AbbVie Inc., a Delaware corporation ("AbbVie"), Oxford Amherst Corporation, a Delaware corporation and a direct wholly owned subsidiary of AbbVie and Oxford Amherst LLC, a Delaware limited liability company and a direct wholly owned subsidiary of AbbVie this option was cancelled in exchange for a cash payment equal to the number of shares subject to the option multiplied by the difference between $261.25 and the exercise price of the option, subject to applicable withholding taxes and pursuant to the procedures set forth in the Merger Agreement.

Documents

1 file

Issuer

PHARMACYCLICS INC

CIK 0000949699

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000949699

Filing Metadata

Form type
4
Filed
May 27, 8:00 PM ET
Accepted
May 28, 6:49 PM ET
Size
66.5 KB
View on SEC.gov